Number of Shares
22,272.00
Current Holdings Value*
kr775,820.00
% of Portfolio
1.84%
Total Estimate Gain
kr4.95 Mil
% of Total Estimate Gain
63.06%

Eaton Vance Hexavest International Equity Fund's Novo Nordisk AS Holding Summary

As of 2021-01-31, EATON VANCE GROWTH TRUST held 22,272.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr775,820.00. This investment constitutes 1.84% of their stock portfolio, and EATON VANCE GROWTH TRUST now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2019Q4. And since then Eaton Vance Hexavest International Equity Fund has made 1 purchases of OCSE:NOVO B, at an average price of kr195.49, for a total of 40,162.00 shares. In addition, there have been 3 sales at an average price of kr204.07 for 17,890.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr410.90, Eaton Vance Hexavest International Equity Fund's estimated gain on his OCSE:NOVO B holdings is kr4.95 Mil, reflecting a 63.06% gain to date.

Eaton Vance Hexavest International Equity Fund OCSE:NOVO B (kr410.90) Holding Chart

Eaton Vance Hexavest International Equity Fund OCSE:NOVO B (kr410.90) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1